Navigation Links
The First Patient Treated Using Celsense MRI Cell Tracking Technology
Date:4/11/2013

Pittsburgh, PA (PRWEB) April 11, 2013

Celsense, Inc. announced today that the first patient to have transplanted cells imaged by magnetic resonance imaging (MRI) using the company’s Cell Sense technology has been treated at the University of Pittsburgh Cancer Institute (UPCI).    The Phase 1 clinical trial was cleared by the US FDA for the purposes of developing information regarding cell migration following administration of live cells.

This application, involving the use of an autologous dendritic cell vaccine to treat colorectal cancer, is the first time the trafficking of a live cell cancer vaccine in patients has been visualized by MRI in the United States. The administration of live cell vaccines is an emerging strategy to treat a variety of cancers.

Investigators believe that the unaided trafficking of dendritic cells to the lymph node is fundamental to the success of this therapeutic strategy. "We are excited that this study is finally moving forward. While this is only the first patient to be imaged in the clinical trial, we expect that data from this study as a whole will lead to improved outcomes for patients receiving live cell vaccines for cancer," said Charlie O'Hanlon, President and CEO of Celsense.

“Where infused therapeutic cells migrate, how many go where, and how long they stay is something about which we have very little data in a clinical setting. To-date there have been few, if any, tools at our disposal to use in obtaining this information in humans,” says cell therapy industry analyst, Lee Buckler, Managing Director of the Cell Therapy Group. “Cell Sense certainly represents one of the first and only cell imaging technologies that has been cleared by a regulatory agency for human use and to that extent it signals a significant step forward
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Finally, the need of nearly every woman wanting to look more beautiful is fulfilled with Crisalix, the first online direct-to-consumer 3D imaging using standard pictures
2. Dr. Ritchie Shoemaker Proudly Announces First Graduate of Shoemaker Protocol Certification Training
3. The First Dedicated Breast Cancer Cell Line Transfection Reagent
4. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
5. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
6. First Time in Philadelphia Is a Success for Pittcon 2013 (Summary Report)
7. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
8. Medifirst Solutions, Inc. Announces Further Update To Shareholders
9. BioMed Realty Trust Declares First Quarter 2013 Common Stock Dividend
10. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
11. First-To-File Patent Law Is Now In Effect, But What Does it Mean?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... and SAN DIEGO , Nov. 20, 2014 ... President and CEO Marc Hedrick , M.D. will present ...   Thursday, December 4, 2014 TIME:    11:15 am ... or paste this URL into your browser,s address bar: ... pre-register to save time and receive event updates. ...
(Date:11/18/2014)... 18, 2014 Cord Blood Registry® (CBR®) ... 10th Annual World Stem Cell Summit, the largest global meeting ... World Stem Cell Summit will be held December 3-5 at ... . The World Stem Cell Summit ... cures and therapies, convening the most prominent figures in the ...
(Date:11/18/2014)... Cirrascale Corporation ®, a ... rackmount computing infrastructure, today announced it will offer ... its GPU-enabled blade server and high-performance workstation product ... proprietary 80-lane Gen3 PCIe switch-enabled risers, the GB5400 ... dual-GPU accelerator cards in a single blade, allowing ...
(Date:11/18/2014)... San Diego, CA (PRWEB) November 17, 2014 ... Emerson of Salk , Dr. Beverly Emerson, a professor in ... behavior of genes. Her most recent discovery points to an ... about Dr. Emerson’s career and how her local research is ... Emerson will present her findings and then join host Cheryl ...
Breaking Biology Technology:Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3Cirrascale® Expands Multi-GPU Peering Solutions with Support for New NVIDIA Tesla K80 Dual-GPU Accelerators 2Cirrascale® Expands Multi-GPU Peering Solutions with Support for New NVIDIA Tesla K80 Dual-GPU Accelerators 3
... 24 Bone Biologics, Inc. announced today that it,s ... development of a recombinant cell line and initial production ... been developing the protein as a platform technology since ... the lab performed by the founding scientists at ...
... today announced,that the company has obtained an exclusive ... proprietary chiral lipid DOTAP Chloride in,Versamune(TM)-HPV and other ... The use of enantiomerically pure DOTAP Chloride shows ... Eprova AG will be providing,enantiomerically pure DOTAP Chloride ...
... Environment of Care managers can now ... and maintain their organization,s environment of care ... of brief, web-based audio interviews with EC experts called ... download at http://www.eheinc.com/ec_bits.htm feature expert advice to ...
Cached Biology Technology:Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences 2PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2
(Date:11/4/2014)... PA) – Temple University School of Medicine announced ... winner, an initiative funded by the Bill & ... Professor of Obstetrics, Gynecology and Reproductive Sciences; and ... Temple University School of Medicine will pursue an ... "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment.", Grand ...
(Date:11/4/2014)... newly published research study examining only marketing directed ... fast food restaurants has found that the majority ... exposed to such marketing tactics. , Authored by ... colleagues, the study is the first to examine ... and exterior of fast food restaurants and its ...
(Date:11/4/2014)... HOUSTON – (Nov. 4, 2014) – A majority of ... and that could have serious consequences for the rainforests ... researchers shows the positive impacts lemurs can have on ... impact their disappearance could have on the region,s rich ... rainforest have fruits eaten by lemurs. Lemurs in ...
Breaking Biology News(10 mins):Temple University School of Medicine receives Grand Challenges Explorations grant 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... 12 new genes that are somewhat strange bedfellows: Some ... and sleep patterns to small increases in glucose levels ... While these associations are surprising, all the genes ... could help explain conditions that have been a mystery. ...
... in metabolism and diabetes has been suggested in new research ... Wellcome Trust Sanger Institute and the MRC Epidemiology Unit in ... the way the body responds to the 24 hour day-night ... and an increased risk of type 2 diabetes. The results ...
... new study presages a real aim of genetics: to look ... individual genetic variants for individual health. The research team, whose ... novel genetic variants that are associated with lipid levels, a ... of ,genetic microscopes, has increased because the methods are in ...
Cached Biology News:New genes present drug targets for managing cholesterol and glucose levels 2New genes present drug targets for managing cholesterol and glucose levels 3Discovery of new gene associated with diabetes risk suggests link with body clock 2The genetic heart of the lipids 2The genetic heart of the lipids 3